Quantitative Assessment of Rectal Dose–Volume Histogram (DVH) Constraint Deviations in Image-Guided Hypofractionated Prostate Radiotherapy

Read full text
Authors: Raouia Ben Amor, Syrine Lahiouel, Roua Toumi, Zeineb Naimi, Ghada Bouguerra, Awatef Hamdoun, Lotfi Kochbati
Cited by: 0

Abstract

Introduction: We aimed to investigate changes in rectal dose during the treatment course for prostate cancer patients treated with hypofractionated radiotherapy with daily image-guidance. Methodology: This study included 20 prostate cancer patients treated with VMAT hypofractionated RT (60 Gy/20 Fr). IMRT- VMAT planning was performed using simulation CT images. Four patients were excluded due to inability to plan with CBCT images. Patient set-up correction shifts was used as a mesure of the daily Inter-fraction motion. The rectum was outlined on both the original treatment plan and the subsequent daily CBCT images by the same investigator. Rectal doses from the daily CT images were recalculated and compared to the original treatment plan, applying clinical acceptance criteria (V60 < 3%, V52.8 < 30%, V48.6 < 50%, and V40.8 < 60%). Rectal volume variations (V0-VX) and dose constraints were assessed for DVH compliance using post-hoc analysis and repeated measures ANOVA. Linear regression was used to evaluate the relationship between mean rectal dose constraints and rectal volume variations across all patients. Results: Data from 16 patients with 240 daily CBCT sets were analyzed. Mean Rectal volume variation was -0.54 [- 69,76-67cc] (Figure1-A). The mean values for V60, V52.8, V48.6, and V40.8 were 2.58[0-6.15], 5.45[0-10.98], 8.47 [1.48-18.01], 11.73[4.41-23.58] and 18.69[8.69-34,91], respectively (Figure1-B). Repeated measures ANOVA analysis revealed that 7,5% (18/240), 93,75% (225/240), 14,5% (35/240), 1,25% (3/240) and 1,25% (3/240) of the subsequent treatment dose distributions did not meet our criterion of V60 < 3%, V57

Fields of Study & Subjects

Advanced Radiotherapy Techniques Radiation Dose and Imaging Prostate Cancer Diagnosis and Treatment

Publication details

Journal / source
OncoDaily Medical Journal
Publication date
1 January 2026